Filing Flows › NeuroPace (NPCE) › Q1 2026
NeuroPace (NPCE) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 12, 2026
NeuroPace (NPCE) reported revenue of $22.1M for the first quarter 2026 (Q1 2026), -2% from a year earlier and -17% from the quarter before. Operating margin was -25.2%, net loss $6.7M (30.3% of revenue).
NeuroPace, Q1 2026: revenue $22.1M (-2% year over year), operating margin -25.2%, net loss $6.7M, operating cash flow −$5.9M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $22.1M | -17% | -2% |
| Operating profit | −$5.6M | — | — |
| Net earnings | −$6.7M | — | — |
| Operating cash flow | −$5.9M | -1266% | — |
What changed
Revenue was $22.1M in Q1 2026, down 2% year over year and down 17% from the previous quarter.
Gross margin was 81.8%, up 4.8 points from Q1 2025. Operating costs exceeded revenue by $5.6M, an operating margin of -25.2%. Operating expenses grew 5% against a revenue fall of 2%. The fastest-growing cost line was General & admin (+20%). The quarter ended with a net loss of $6.7M, wider than the previous quarter's $2.7M loss.
Operating cash flow was −$5.9M. Non-cash charges added back $60K of depreciation and $2.3M of share-based compensation. Working capital and other items used $1.5M. Capital expenditures of $117K exceeded it, leaving free cash flow of −$6.0M.
Questions
What was NeuroPace's revenue in the first quarter 2026?
NeuroPace (NPCE) reported revenue of $22.1M for the first quarter 2026 (Q1 2026), -2% from a year earlier and -17% from the quarter before.
Was NeuroPace profitable in the first quarter 2026?
Operating loss was $5.6M (-25.2% of revenue) and net loss $6.7M.
Source: NeuroPace 10-Q on SEC EDGAR.